3D-Bioprinted Collagen Peptide Scaffolds Guide Stem Cells to Grow Ligament-Like Tissue | Research

The takeaway

A new collagen peptide–xanthan gum hydrogel enables 3D bioprinting of self-healing scaffolds that direct human stem cells toward ligament tissue formation.

Scleraxis upregulated at 28 days
Scleraxis is a key transcription factor specific to ligament and tendon development — its expression confirms the bioprinted stem cells were differentiating toward ligament tissue

What the researchers found

Researchers developed a 3D-bioprinted hydrogel scaffold using methacrylated collagen peptide combined with xanthan gum (COPMA-XG) that overcomes the traditional limitations of collagen peptides in tissue engineering — namely low viscosity and poor printability. The resulting bioinks showed self-healing properties, rapid UV-curing, tunable mechanical strength, and stable structure in culture medium.

When loaded with human bone marrow stem cells (hMSCs) and cultured for 28 days, the bioprinted constructs were biocompatible and promoted stem cell proliferation and differentiation into ligament-like tissue, with increased production of extracellular matrix, collagen type I, and scleraxis (a ligament-specific marker).

Why it matters

Ligament injuries are common and heal poorly due to limited blood supply. Current surgical options often use grafts that have drawbacks. Collagen peptides are promising for tissue regeneration because they're water-soluble and bioactive, but they've been difficult to 3D-print into stable structures. This study solves that problem by combining collagen peptides with xanthan gum, creating a printable, self-healing scaffold that actually directs stem cells toward ligament tissue formation. This could eventually enable custom-printed ligament replacements.

The numbers in context

28-day culture period · hMSCs differentiation confirmed · Increased collagen type I production · Increased scleraxis expression · Self-healing hydrogels · UV-curable

How the study worked

The researchers first synthesized methacrylated collagen peptide (COPMA) hydrogels with UV-curing capability and tunable mechanical properties. They then mixed COPMA with xanthan gum (XG) at various ratios to create bioinks with improved printability and mechanical strength. The COPMA-XG bioinks were used to 3D-bioprint constructs containing human bone marrow mesenchymal stem cells. The constructs were evaluated for self-healing, printability, structural stability, biocompatibility, and stem cell differentiation toward ligament lineage over 28 days.

Who was studied

Human bone marrow mesenchymal stem cells (in vitro)

What this study cannot tell us

This is an in vitro study — the bioprinted constructs have not been tested in animal models or humans. Long-term mechanical durability under physiological loading conditions (as experienced in a real ligament) was not assessed. The transition from lab-scale bioprinting to clinically relevant construct sizes and implantation remains a significant challenge.

How to read the evidence

This is a preliminary in vitro study demonstrating material development and proof-of-concept stem cell differentiation. No animal or human testing was performed. The evidence is preliminary but provides a solid foundation for further development.

When this study was published

Published in 2025, this study represents the current state of peptide-based bioprinting for tissue engineering applications.

The bigger picture

Bioprinting with peptide-based materials is an emerging frontier in regenerative medicine. Collagen peptides offer key advantages over full collagen — they're water-soluble, easier to process, and retain bioactivity. This study demonstrates that the printability barrier can be overcome through smart material combinations. If successfully translated, peptide-based bioprinted tissues could transform orthopedic surgery, offering patient-specific tissue replacements that integrate naturally with the body. The approach is part of a broader shift toward using peptides not just as drugs but as structural biomaterials.

Questions still open

Will COPMA-XG scaffolds maintain mechanical integrity and promote ligament formation when implanted in animal models under physiological loading?
Can this bioink platform be adapted for other connective tissues like tendons, cartilage, or meniscus?
How does the degradation rate of COPMA-XG scaffolds match the timeline of natural ligament regeneration?

Common questions

What are collagen peptides and how are they different from collagen?

Collagen peptides are smaller fragments of collagen, the main structural protein in connective tissues like skin, tendons, and ligaments. Unlike full collagen, which is difficult to dissolve and process, collagen peptides are water-soluble and easier to work with in the lab. They retain many of the biological signals that help cells attach, grow, and form tissue.

What makes this bioink special for 3D printing?

Collagen peptides alone are too thin and watery to hold a 3D-printed shape. By adding xanthan gum (a natural thickening polysaccharide) and chemical modifications for UV-curing, the researchers created a bioink that prints well, heals itself if damaged, and maintains its structure in cell culture. This combination of printability, self-healing, and bioactivity is unusual and makes it suitable for tissue engineering.

Read the original research

Mechanical Reinforced and Self-healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide-Xanthan Gum Constructs for Ligament Regeneration.

Advanced healthcare materials, 14(25), e2502341

View on PubMed ↗Publisher’s paper ↗

Citation

Weng, Hongjuan; Decarli, Monize Caiado; He, Lei; Chen, Wen; van Rijt, Sabine; Bernaerts, Katrien V; Moroni, Lorenzo. (2025). Mechanical Reinforced and Self-healing Hydrogels: Bioprinted Biomimetic Methacrylated Collagen Peptide-Xanthan Gum Constructs for Ligament Regeneration.. Advanced healthcare materials, 14(25), e2502341. https://doi.org/10.1002/adhm.202502341